Clinical trial
A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in…
NCT00199407 · Kyowa Kirin, Inc., Industry · Completed
Key facts
| NCT number | NCT00199407 |
|---|---|
| Title | A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa |
| Official title | A 12-week, Double Blind, Placebo-controlled, Randomized, Parallel Group, Multicenter, Fixed Dose Study to Evaluate the Efficacy and Safety of a 20 mg/d Oral Dose of KW-6002 (Istradefylline) as Treatment for Parkinson's Disease in Patients With Motor Response Complications on Levodopa/Carbidopa… |
| Lead sponsor | Kyowa Kirin, Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Parkinson's Disease |
| Intervention type | Drug |
| Interventions | Istradefylline (KW-6002) |
| Enrollment | 230 |
| Start date | Jun 1, 2004 |
| Primary completion | Nov 1, 2005 |
| Completion | Jan 1, 2006 |
| First posted | Sep 20, 2005 |
| Last update posted | Apr 25, 2024 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: